insights_auto
Why is EYPT down 2,19%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
3,34 USD
arrow_downward
-2,19%(-0,075) 1D
30-сен., 11:08:05 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
3,42 USD
High
3,45 USD
Low
3,30 USD
Mkt. cap
288,38 млн
Avg. vol.
4,58 млн
Volume
654,54 миң
52-wk high
19,11 USD
52-wk low
3,26 USD
EPS
-3,74 USD
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Open
3,42 USD
High
3,45 USD
Low
3,30 USD
Mkt. cap
288,38 млн
Avg. vol.
4,58 млн
Volume
654,54 миң
52-wk high
19,11 USD
52-wk low
3,26 USD
EPS
-3,74 USD
Beta
1,63
Shares outstanding
86,21 млн
No. of employees
214
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees214
Founded2000
HeadquartersУотертаун, Массачусетс, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteeyepoint.bio